(Q40170553)

18 September 2017

Beta-arrestin and Mdm2 mediate IGF-1 receptor-stimulated ERK activation and cell cycle progression (English)

1 reference

18 September 2017

7

Robert J Lefkowitz

1 reference

18 September 2017

Leonard Girnita

1

1 reference

18 September 2017

Sudha K Shenoy

2

1 reference

18 September 2017

Bita Sehat

3

1 reference

18 September 2017

Radu Vasilcanu

4

1 reference

18 September 2017

Daiana Vasilcanu

5

1 reference

18 September 2017

Ada Girnita

6

1 reference

18 September 2017

Olle Larsson

8

1 reference

18 September 2017

language of work or name

English

0 references

publication date

15 February 2007

1 reference

Journal of Biological Chemistry

18 September 2017

1 reference

18 September 2017

282

1 reference

18 September 2017

15

1 reference

18 September 2017

11329-11338

1 reference

IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice

18 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

Expression and growth dependency of the insulin-like growth factor I receptor in craniopharyngioma cells: a novel therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

{beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

Role of insulin-like growth factor 1 receptor signalling in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

Transduction of receptor signals by beta-arrestins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

Historical review: a brief history and personal retrospective of seven-transmembrane receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

beta-Arrestin: a protein that regulates beta-adrenergic receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

Trafficking patterns of beta-arrestin and G protein-coupled receptors determined by the kinetics of beta-arrestin deubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

Receptor-specific ubiquitination of beta-arrestin directs assembly and targeting of seven-transmembrane receptor signalosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

Desensitization, internalization, and signaling functions of beta-arrestins demonstrated by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

beta-arrestins regulate mitogenic signaling and clathrin-mediated endocytosis of the insulin-like growth factor I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

Insulin and insulin-like growth factor I receptors utilize different G protein signaling components

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

Molecular and cellular aspects of the insulin-like growth factor I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

Real-time monitoring of ubiquitination in living cells by BRET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

Mono- versus polyubiquitination: differential control of p53 fate by Mdm2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

Protein regulation by monoubiquitin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

Distinct monoubiquitin signals in receptor endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

Site-specific monoubiquitination of IkappaB kinase IKKbeta regulates its phosphorylation and persistent activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

Continuous ERK activation downregulates antiproliferative genes throughout G1 phase to allow cell-cycle progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M611526200

ERK MAP kinase in G cell cycle progression and cancer

21 January 2018

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1074/JBC.M611526200

Domains of the insulin-like growth factor I receptor required for the activation of extracellular signal-regulated kinases

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1074/JBC.M611526200

The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1074/JBC.M611526200

Blockade of the extracellular signal-regulated kinase pathway induces marked G1 cell cycle arrest and apoptosis in tumor cells in which the pathway is constitutively activated: up-regulation of p27(Kip1)

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1074/JBC.M611526200

Identifiers

DOI

10.1074/JBC.M611526200

1 reference

18 September 2017

1 reference